Andrea Michele Sartori, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Bladder | 7 | 2021 | 1152 | 1.790 |
Why?
|
| Urination | 3 | 2020 | 203 | 1.370 |
Why?
|
| Urodynamics | 5 | 2021 | 346 | 1.210 |
Why?
|
| Spinal Cord Injuries | 6 | 2022 | 924 | 1.180 |
Why?
|
| Urinary Bladder, Neurogenic | 4 | 2021 | 173 | 1.140 |
Why?
|
| Nerve Fibers, Unmyelinated | 1 | 2021 | 98 | 0.750 |
Why?
|
| Bacteriuria | 1 | 2021 | 102 | 0.730 |
Why?
|
| Interneurons | 2 | 2021 | 587 | 0.670 |
Why?
|
| Urology | 1 | 2024 | 400 | 0.640 |
Why?
|
| Peptidomimetics | 1 | 2019 | 31 | 0.640 |
Why?
|
| Urinary Tract | 1 | 2022 | 304 | 0.630 |
Why?
|
| Urination Disorders | 1 | 2020 | 238 | 0.620 |
Why?
|
| Urinary Tract Infections | 2 | 2021 | 801 | 0.580 |
Why?
|
| Biological Assay | 1 | 2020 | 623 | 0.550 |
Why?
|
| Deep Brain Stimulation | 2 | 2022 | 829 | 0.540 |
Why?
|
| Rats, Inbred Lew | 6 | 2022 | 1159 | 0.460 |
Why?
|
| Oligopeptides | 1 | 2019 | 1179 | 0.430 |
Why?
|
| Parkinson Disease | 1 | 2022 | 2867 | 0.300 |
Why?
|
| Practice Guidelines as Topic | 1 | 2024 | 7400 | 0.270 |
Why?
|
| Cell Proliferation | 1 | 2019 | 10423 | 0.210 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 5665 | 0.200 |
Why?
|
| Urinary Sphincter, Artificial | 1 | 2021 | 23 | 0.190 |
Why?
|
| Urologic Diseases | 1 | 2024 | 247 | 0.190 |
Why?
|
| Suburethral Slings | 1 | 2021 | 72 | 0.180 |
Why?
|
| Melanoma | 1 | 2019 | 5694 | 0.170 |
Why?
|
| Rats | 6 | 2022 | 23705 | 0.170 |
Why?
|
| Sacrum | 1 | 2021 | 275 | 0.170 |
Why?
|
| Urinary Incontinence, Stress | 1 | 2021 | 181 | 0.170 |
Why?
|
| Skin Neoplasms | 1 | 2019 | 5809 | 0.160 |
Why?
|
| Electromyography | 2 | 2021 | 1393 | 0.160 |
Why?
|
| Urethra | 2 | 2018 | 405 | 0.160 |
Why?
|
| Urinary Bladder, Overactive | 1 | 2020 | 115 | 0.160 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2019 | 103 | 0.150 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2019 | 254 | 0.150 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2019 | 355 | 0.150 |
Why?
|
| Urinary Catheterization | 1 | 2018 | 193 | 0.140 |
Why?
|
| Neostriatum | 1 | 2018 | 247 | 0.140 |
Why?
|
| Europe | 1 | 2024 | 3423 | 0.140 |
Why?
|
| K562 Cells | 1 | 2019 | 640 | 0.140 |
Why?
|
| Urinary Incontinence | 1 | 2021 | 490 | 0.140 |
Why?
|
| Transurethral Resection of Prostate | 1 | 2017 | 79 | 0.140 |
Why?
|
| Capillary Permeability | 1 | 2019 | 773 | 0.130 |
Why?
|
| Models, Animal | 2 | 2020 | 2114 | 0.130 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2018 | 485 | 0.130 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 13632 | 0.130 |
Why?
|
| Autonomic Nervous System | 1 | 2020 | 704 | 0.120 |
Why?
|
| Bacteriophages | 1 | 2017 | 378 | 0.110 |
Why?
|
| Mice, SCID | 1 | 2019 | 2621 | 0.110 |
Why?
|
| Animals | 12 | 2022 | 168089 | 0.110 |
Why?
|
| Nervous System Diseases | 1 | 2024 | 1663 | 0.110 |
Why?
|
| Tumor Burden | 1 | 2019 | 1892 | 0.100 |
Why?
|
| Wakefulness | 1 | 2019 | 1264 | 0.100 |
Why?
|
| Corpus Striatum | 1 | 2018 | 1234 | 0.100 |
Why?
|
| Lumbar Vertebrae | 1 | 2021 | 1876 | 0.100 |
Why?
|
| Societies, Medical | 1 | 2024 | 3923 | 0.100 |
Why?
|
| Autoantibodies | 1 | 2019 | 2119 | 0.090 |
Why?
|
| Antibodies | 1 | 2019 | 2415 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 1 | 2019 | 3590 | 0.090 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 3593 | 0.090 |
Why?
|
| Energy Metabolism | 1 | 2018 | 2877 | 0.070 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 2813 | 0.070 |
Why?
|
| Stroke | 2 | 2019 | 9721 | 0.070 |
Why?
|
| Hippocampus | 1 | 2019 | 3754 | 0.070 |
Why?
|
| Cell Movement | 1 | 2019 | 5195 | 0.070 |
Why?
|
| Ultrasonography | 1 | 2019 | 5969 | 0.070 |
Why?
|
| Brain Ischemia | 1 | 2019 | 3032 | 0.060 |
Why?
|
| Humans | 14 | 2024 | 761222 | 0.050 |
Why?
|
| Multiple Sclerosis | 1 | 2018 | 3222 | 0.050 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 4947 | 0.050 |
Why?
|
| Female | 9 | 2022 | 392552 | 0.050 |
Why?
|
| Tibial Nerve | 1 | 2020 | 50 | 0.040 |
Why?
|
| Recovery of Function | 2 | 2022 | 2981 | 0.040 |
Why?
|
| Diet | 1 | 2018 | 8048 | 0.040 |
Why?
|
| Diagnostic Techniques, Urological | 1 | 2019 | 28 | 0.040 |
Why?
|
| Locomotion | 1 | 2022 | 388 | 0.040 |
Why?
|
| Switzerland | 1 | 2020 | 319 | 0.040 |
Why?
|
| Receptors, Serotonin, 5-HT3 | 1 | 2019 | 44 | 0.040 |
Why?
|
| Urologic Surgical Procedures | 1 | 2021 | 298 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2019 | 748 | 0.040 |
Why?
|
| Pyramidal Tracts | 1 | 2019 | 251 | 0.040 |
Why?
|
| Brain Stem | 1 | 2022 | 858 | 0.040 |
Why?
|
| Organ Culture Techniques | 1 | 2019 | 792 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2019 | 9520 | 0.030 |
Why?
|
| Obesity | 1 | 2018 | 12940 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2019 | 23419 | 0.030 |
Why?
|
| Electrodes | 1 | 2018 | 611 | 0.030 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 18222 | 0.030 |
Why?
|
| Spinal Cord | 1 | 2022 | 1807 | 0.030 |
Why?
|
| Male | 6 | 2021 | 360703 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2019 | 1347 | 0.020 |
Why?
|
| Central Nervous System | 1 | 2019 | 1333 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2019 | 2636 | 0.020 |
Why?
|
| Weight Gain | 1 | 2018 | 2349 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2020 | 64681 | 0.020 |
Why?
|
| Mice | 3 | 2019 | 81330 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 10218 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2017 | 12341 | 0.010 |
Why?
|
| Neurons | 1 | 2019 | 9429 | 0.010 |
Why?
|
| Quality of Life | 1 | 2020 | 13367 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2021 | 80675 | 0.010 |
Why?
|
| Brain | 1 | 2019 | 27094 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 221120 | 0.000 |
Why?
|